Techniclone Seeks OK for Cancer Tests
Barbara Marsh covers health care for The Times. She can be reached at (714) 966-7762 and at [email protected]
Techniclone Corp. reached a milestone Monday.
The Tustin developer of cancer therapies said it applied for regulatory approval to begin testing its experimental treatment for brain cancer in human beings.
Later this year, the company intends to begin preparing clinical sites for testing the therapy. The company is trying to develop treatments that attack cancer by targeting dying tissue.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
